Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Increased pulse rate01:17

Increased pulse rate

Tachycardia is a condition marked by an abnormally fast or irregular heart rate, surpassing the typical resting rate. In adults, tachycardia is characterized by a pulse rate ranging from 100 to 180 beats per minute. The increased heart rate can result in inadequate blood flow to various body parts, ultimately diminishing the oxygen supply to organs and tissues.
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Premature Ventricular Contractions as a Target for Arrhythmogenic Right Ventricular Cardiomyopathy Trials PVC in ARVC trials.

Heart rhythm·2026
Same author

Pregnancy in the broad phenotype and genotype spectrum of disease-causing desmosomal variant-positive women.

Journal of cardiovascular medicine (Hagerstown, Md.)·2026
Same author

External validation of the DSP-risk score for prediction of clinically significant ventricular arrhythmias in primary prevention patients with desmoplakin cardiomyopathy-associated genetic variants.

Heart rhythm·2026
Same author

RBM20 Truncating Variants and Human Cardiomyopathy.

JAMA cardiology·2026
Same author

Imaging Naxos disease and related cardiocutaneous syndromes: the NAXCARE multimodality approach.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026
Same author

Evolution and Transformation of Hypertrophic Cardiomyopathy From a High Risk to a Treatable Low Mortality Disease With Contemporary Clinical Research Strategies.

Journal of the American Heart Association·2026

相关实验视频

Updated: Jul 9, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

过度缩性心肌病变性是一种心肌疾病.

Perry Elliott1, William J McKenna

  • 1University College London, London, UK.

Lancet (London, England)
|June 9, 2004
PubMed
概括

缺血性心肌病,一种遗传性心脏病,导致无法解释的左心室缩,其结果是不同的. 管理策略取决于遗传因素和患者特定条件,以获得最佳的护理.

科学领域:

  • 心脏病学 心脏病学
  • 遗传学 是一个遗传学.
  • 内部医学 内部医学

背景情况:

  • 增高性心肌病变 (HCM) 是一种常见的遗传性心脏病,其特征是无法解释的左心室增高.
  • HCM呈现出广泛的临床表现,从无症状病例到严重的运动不耐受和心律失常.
  • 疾病的进展和并发症,包括心脏突然死亡,心力衰竭和中风,每年风险为1-2%,受遗传,病理和生理因素的影响.

研究的目的:

  • 审查被诊断患有不明原因心肌缩的患者的管理.
  • 强调遗传和病理生理基质在指导高性心肌病的临床决策中的作用.

主要方法:

  • 综述现有关于多变性心肌病的文献.
  • 分析影响临床过程和结果的因素.
  • 基于患者子集的治疗干预措施的评估.

主要成果:

  • HCM的临床过程和预后在个体之间具有很大的变化.
  • 对突发死亡,心力衰竭和中风等并发症的风险分层至关重要,但取决于个体患者的因素.
  • 特定的治疗干预措施,如隔膜切除,肌切除术和植入式心脏转换器-除器,适用于特定的患者群体.

结论:

更多相关视频

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

相关实验视频

Last Updated: Jul 9, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

  • 遗传咨询和彻底的临床风险分层对于所有患有HCM的患者至关重要.
  • 个性化管理策略,由潜在的遗传异常和病理生理特征来告知,是优化超性心肌病患者结果的关键.